KCR

Contract Research Organization Serviceskcrcro.com

KCR is a privately held, Berlin-based Contract Research Organization founded in 1997 that delivers clinical development solutions to pharmaceutical and biotechnology sponsors, with a workforce of 501-1,000 employees.

Company typePrivate
Founded1997
HeadquartersBerlin, Germany
Headcount501–1,000
GTM typeB2B
OfferingServices

What KCR does

KCR is a privately held Contract Research Organization (CRO) headquartered in Berlin, Germany, founded in 1997. The firm provides clinical development solutions to pharmaceutical and biotechnology sponsors, operating in the mid-tier CRO segment with a workforce of 501-1,000 employees. Its corporate website is kcrcro.com and its senior leadership comprises Mike Jagielski as President & CEO and Doug Bain as Chief Technology Officer. Beyond these firmographic anchors, no specific therapeutic-area focus, service-line mix, technology platform, geographic footprint beyond Berlin, pricing model, or named customer references are documented in the available source material.

The supplied input set contains substantial noise that does not pertain to KCR the CRO: multiple source blocks refer to K. Chandrashekar Rao, a former Chief Minister of Telangana, India, in the context of legal and political matters including the PC Ghose Commission investigation of the Kaleshwaram Lift Irrigation Project, a phone-tapping SIT matter, and CBI handover discussions; an additional block reproduces the ICON plc website content for biotech outsourcing services. These sources are unrelated to KCR GmbH/KCR CRO and have been excluded from substantive analysis. No funding rounds, acquisitions, partnerships, product launches, regulatory milestones, or customer disclosures attributable to KCR the CRO were extractable.

Given the thinness of first-party evidence, the company should be characterized as an established, mid-sized European CRO with 28 years of operating history, a Berlin cost base, and standard CRO service delivery — with all other strategic, financial, and competitive dimensions flagged as data gaps rather than inferred.

KCR firmographics

Firmographics

Name: KCR
Legal name: KCR (K. Chandrashekar Rao)
Website: https://kcrcro.com
Company type: Private
Founded year: 1997
Operating status: Operating
Headcount range: 501–1,000 employees
Short description: KCR is a privately held, Berlin-based Contract Research Organization founded in 1997 that delivers clinical development solutions to pharmaceutical and biotechnology sponsors, with a workforce of 501-1,000 employees.
Ownership category
akta.pro rank

KCR industry classification

Industry

Product category: Contract Research Organization Services
NAICS: Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC: Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry: Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

Clinical research services
Contract research organization
Clinical development solutions
Clinical trial services
Biopharma research services

Where KCR is headquartered

Location

Headquarters

HQ city: Berlin
HQ country: Germany
HQ region: Europe

Markets served

KCR business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

KCR product offering

Product offering

Core offering

KCR is a Contract Research Organization (CRO) that provides clinical development solutions to pharmaceutical and biotechnology sponsors. Headquartered in Berlin, Germany and founded in 1997, the firm supports clinical trial execution and related development activities for biopharma clients.

Differentiator

Problem solved

Functional benefit

Products and services

Clinical Development Solutions CRO services spanning the clinical development lifecycle, provided to pharmaceutical and biotechnology sponsors. Delivered from the Berlin, Germany headquarters.

Companies that use KCR

Customer profile

Ideal customer profiles1 record

KCR technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

KCR competitors and assessment

Company assessment

Direct peers

ICON plc: Global clinical CRO with end-to-end Phase I–IV services across biotech and pharma sponsors; directly comparable to KCR as a clinical development outsourcing competitor, though operating at materially larger scale.
Parexel International: Mid-to-large clinical CRO focused on biotech and biopharma sponsors; directly comparable operating model to KCR with similar therapeutic-area clinical development emphasis.
Medpace Holdings: Mid-sized full-service CRO with concentrated biotech sponsor focus and strong operational execution reputation; highly comparable in scale and clinical development positioning to KCR.
Worldwide Clinical Trials: Mid-sized, therapeutically-focused clinical CRO with strong CNS, cardiometabolic, and rare disease franchises; comparable to KCR in scale and clinical development service model.
CTI Clinical Trial & Consulting Services: Mid-sized private CRO headquartered in Cincinnati with strong European delivery footprint; directly comparable to KCR in size, therapeutic focus, and clinical development offering.
Fortrea Holdings: Mid-to-large clinical CRO carved out from Labcorp Drug Development; competes directly with KCR for Phase II–IV clinical trial work across biotech and pharma sponsors.
Syneos Health: Clinical CRO and commercial solutions provider; directly comparable to KCR as a clinical development outsourcing peer, with broader commercial/launch services as a distinguishing feature.
Clinscience (previously Clinipace Worldwide): Mid-sized, therapeutically-focused clinical CRO with European operational roots; comparable to KCR in scale, therapeutic focus, and clinical development service model.

Broad incumbents

IQVIA: Largest global CRO/clinical technology player with R&D Solutions and broader data/analytics offerings; competes with KCR for Phase II–III clinical trial work while also offering adjacent commercial and real-world evidence services.
Charles River Laboratories: Broader life sciences services platform spanning preclinical through clinical; competes with KCR particularly at the preclinical-clinical handoff and through its clinical CRO subsidiary.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

KCR financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KCR leadership team

Management profile

Number of profiles

Profiles2 records

KCR funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KCR M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KCR

What does KCR do?

Is KCR a public or private company?

KCR is a private company. It is classified as unknown and is currently operating.

When was KCR founded?

KCR was founded in 1997. It employs 501 to 1,000 people.

Where is KCR based?

KCR is headquartered in Berlin, Germany, in the Europe region.

Who are KCR's main competitors?

Direct peers on record are ICON plc, Parexel International, Medpace Holdings, Worldwide Clinical Trials, CTI Clinical Trial & Consulting Services, Fortrea Holdings, Syneos Health and Clinscience (previously Clinipace Worldwide). Broad incumbents are IQVIA and Charles River Laboratories.

Does KCR have an API?

No public API is recorded for KCR.

What industry is KCR in?

KCR's product category is Contract Research Organization Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 541714 and its SIC code is 8731.